CGEN Compugen

• None no insider bought on the open market
• None no sales outside a trading plan
• $118K sold by 2 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Zurit Levine SVP, Business Development
   Planned sale
   $4,688 1,875 shares at $2.50 6% of stake
   Traded Jul 9 Filed Jul 13
   ↗
3. Zurit Levine SVP, Business Development
   Planned sale
   $6,400 2,000 shares at $3.20 6.4% of stake
   Traded Apr 24 Filed Apr 27
   ↗
4. Eran Ophir CEO
   Planned sale
   $16K 5,000 shares at $3.20 31% of stake
   Traded Apr 24 Filed Apr 27
   ↗
5. Eran Ophir CEO
   Planned sale
   $15K 5,000 shares at $2.90 31% of stake
   Traded Apr 14 Filed Apr 15
   ↗
6. Zurit Levine SVP, Business Development
   Planned sale
   $5,600 2,000 shares at $2.80 6.4% of stake
   Traded Apr 14 Filed Apr 15
   ↗
7. Zurit Levine SVP, Business Development
   Planned sale
   $8,013 3,125 shares at $2.56 9.6% of stake
   Traded Apr 10 Filed Apr 15
   ↗
8. Zurit Levine SVP, Business Development
   Planned sale
   $19K 7,875 shares at $2.38 21% of stake
   Traded Apr 7–8 Filed Apr 9
   ↗
9. Zurit Levine SVP, Business Development
   Planned sale
   $7,700 3,500 shares at $2.20 11% of stake
   Traded Apr 1 Filed Apr 3
   ↗
10. Eran Ophir CEO
    Planned sale
    $12K 5,625 shares at $2.21 33% of stake
    Traded Apr 1 Filed Apr 3
    ↗
11. Zurit Levine SVP, Business Development
    Planned sale
    $24K 11,875 shares at $2.04 29% of stake
    Traded Mar 26 Filed Mar 30
    ↗

Also filed in the last 12 months, not counted as buying or selling: 14 option exercises and 9 stock grants.